CureCancer helps patients with their therapy and to communicate with their doctor!
A recent study showed that CureCancer helped patients record their symptoms and communicate them to their doctor, in order to achieve timely and effective treatment .
Nine out of 10 participants said their registration was very easy and they would recommend the platform to others.
Read some of the patient's comments:
I do not forget my medication, I do not need to remember which day one treatment ends and when the other begins, I do not miss my exams, with one click I have access to my history from everywhere, it is easier for the doctor to see it without me having to carry my test results with me.
I received immediate answers on the subject of my health, my doctor was better informed about my state of health, I will recommend it to others so they can benefit.
I felt safe, I contacted my doctor without having to meet at the hospital, reduced my inconvenience with unnecessary visits, saved time and money, minimized my risk of contracting the virus by avoiding hospital visits.
Everything is organized on one platform, I like the design and usability of the page.
I like the idea of the application for the general good, the direct contact with my doctor and the sense of safety that it gives me, I like the fact that my whole team of doctors can be informed at any time about the course of my health and cooperate with each other.
In the Community I shared my experiences with others
 CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during covid-19 and reduces costs. A feasibility and satisfaction study.
D. Galiti (1), S. Agelaki (2), A. Karampeazis (2), H. Linardou (2), N. Tsoukalas (2), E. Arvanitou (2), E. Georgopoulou (2), C Vallilas (2), K. Syrigos (2), S. Sgourou (2), S. Kokkali-Zervos (2), E. Stamatogianni (2), A. Boutis (2), A. Christopoulou (2), L. Kontovinis (2), A. Mala (2), G. Rigas (2), Z. Saridaki-Zoras (2), O. Nicolatou-Galitis (1), I. Boukovinas (2)
(1) Hellenic Society of Medical Oncology, Athens, Greece, (2) CureCancer, Athens, Greece
The study was presented at the European Congress of Oncology - ESMO, 17-22 September 2020.